This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the US therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2016 Emerging Opportunities in the US Therapeutic Drug Monitoring (TDM) Market is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 249 pages and 19 tables
SIMILAR MARKET STUDIES
This report provides an overview of the French hematology market, including sales and market shares of leading instrument and consumable suppliers, as well as test volume and sales forecasts by market segment.Table of ContentsBusiness EnvironmentMarket StructureMarket Size, Growth, and Major Suppliers' Market SharesList of TablesHematology Test Volume Forecasts by Market ...
June 2016 | $0 | View Details >>
This report is a crucial resource for industry executives and anyone looking to access key information about "Funtalk China Holdings Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
April 2014 | $125 | View Details >>
Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6400.This new 366-page report from VPGMarketResearch.com contains 108 tables and provides analysis of the global respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this ReportThis report ...
October 2015 | $6200 | View Details >>
Notes: Sales, means the sales volume of High Throughput Screening (HTS) Revenue, means the sales value of High Throughput Screening (HTS) This report studies sales (consumption) of High Throughput Screening (HTS) in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, ...
October 2016 | $4000 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research